Protective Effects of Platycodin D3 on Airway Remodeling and Inflammation via Modulating MAPK/NF-κB Signaling Pathway in Asthma Mice

Figure 5

PD3 treatment reduced the expression of proteins associated with the MAPK/NF-κB signaling pathway. (a) Bands of NF-κBp65 and p-NF-κBp65, p38 and p-p38, ERK1/2 and p-ERK1/2, and JNK1/2 and p-JNK1/2 proteins. PD3 treatment reduced the expression levels of NF-κBp65 and p-NF-κBp65 (b), p38 and p-p38 (c), ERK1/2 and p-ERK1/2 (d), and JNK1/2 and p-JNK1/2 (e) proteins. PD3, platycodin D3. Data were expressed as mean ± SD, n = 3. Compared with the control group, ^★, ^★★; compared with the asthma group, ^#, ^##.

(a)

(b)

(c)

(d)

(e)